Enhancing remyelination in multiple sclerosis via M1 muscarinic acetylcholine receptor. [PDF]
Chen K, Park E, Abd-Elrahman KS.
europepmc +1 more source
Research progress in myocardial function and diseases related to muscarinic acetylcholine receptor (Review). [PDF]
Shen C, Zuo Q, Shao Z, Lin Y, Chen S.
europepmc +1 more source
From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trials. [PDF]
Meyer JM+4 more
europepmc +1 more source
Acetylcholine muscarinic M2 receptor maintains human Schwann-like adipose-derived phenotype in the absence of differentiating medium. [PDF]
Piovesana R, Faroni A, Tata AM, Reid AJ.
europepmc +1 more source
Discovery of Pre-Clinical Candidate <b>VU6008055</b>/<b>AF98943</b>: A Highly Selective, Orally Bioavailable, and Structurally Distinct Tricyclic M<sub>4</sub> Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) with Robust In Vivo Efficacy. [PDF]
Engers JL+26 more
europepmc +1 more source
Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptors [PDF]
A Krejčí+43 more
core +2 more sources
Long-term muscarinic inhibition increases intrinsic excitability through the upregulation of A-type potassium currents in cortical neurons. [PDF]
Riquelme D+4 more
europepmc +1 more source
M. Yamada+10 more
semanticscholar +1 more source
A Brief Overview of Cholinergic and Phosphodiesterase-5 Inhibitors in Diabetic Bladder Dysfunction. [PDF]
Kallinikas G+15 more
europepmc +1 more source
Muscarinic Modulation of Network Excitability and Short-Term Dynamics in the Dorsal and Ventral Hippocampus. [PDF]
Tsotsokou G+2 more
europepmc +1 more source